Use of growth hormone secretagogues for treatment of physical performance decline
CA 2351897 A1 · Owner: Landschulz, William Harras · Inventors: Maclean, David Burton; Landschulz, William Harras
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention is directed to methods for treating age-related decline in physical performance which comprises administering .a growth hormone secretagogue, a prodrug thereof or a pharmaceutically acceptable salt of said secretagogue or said prodrug. More preferably the present invention provides , such, methods wherein the growth hormone secretagogue is a compound of Formula I: (see formula I), a prodrug thereof or a pharmaceutically acceptable salt of said secretagogue or, said prodrug.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 27, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 27, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.